Doctor Concetta Di Nora

Doctor Concetta Di Nora

Hospital Santa Maria della Misericordia, Udine (Italy)

Member of:

Cardiology Specialist interested in advanced heart failure management, heart transplantation, assisted ventricular devices therapy, and echocardiography.

Presentations

Recipient or donor age in heart transplantation:which one fits more?

Event: ESC Congress 2019

Topic: Heart Transplantation

Session: Stage D Heart Failure

Access

Donor age in heart transplantation: results and controversies

Event: Heart Failure 2019

Topic: Heart Transplantation

Session: Chronic Heart Failure – Treatment

Access

Carotid artery atherosclerosis and stiffness: comparison of different metabolic measures

Event: EuroEcho-Imaging 2016

Topic: Aortic atherosclerosis

Session: Diseases of the aorta

Access

Paradoxical low-flow low-gradient aortic stenosis: an intermediate state between moderate and severe aortic stenosis?

Event: EuroEcho-Imaging 2016

Topic: Aortic stenosis

Session: Heart valves

Access

Ejection fraction-velocity ratio in predicting symptoms in severe aortic stenosis

Event: EuroEcho-Imaging 2016

Topic: Aortic stenosis

Session: Heart valves

Access

The effect of beta-blocker therapy in HF patients with high comorbidity burden: interpreting data in community setting

Event: HEART FAILURE 2016

Topic: Beta blockers

Session: Beta blockers

Access

Comparing prognostic role of atrial fibrillation in predominantly HF elderly patients with HFrEF and HFpEF in community setting.

Event: HEART FAILURE 2016

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation

Access

Quantitative contributor of comorbidities in HF patients according to HF phenotypes.

Event: HEART FAILURE 2016

Topic: Prognosis

Session: Moderated Poster Session 2 - Cardiomyopathy

Access

Systolic blood pressure target: a new challenge in cardiovascular prevention in community-based population?

Event: HEART FAILURE 2016

Topic: Prognosis

Session: Prognosis

Access

Prognostic impact of polypharmacy drugs across heart failure phenotypes: an unmet need.

Event: HEART FAILURE 2016

Topic: Drug therapy, other

Session: Drug therapy, other

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Concetta Di Nora

Biography

Contributor content

Recipient or donor age in heart transplantation:which one fits more?

Donor age in heart transplantation: results and controversies

Carotid artery atherosclerosis and stiffness: comparison of different metabolic measures

Paradoxical low-flow low-gradient aortic stenosis: an intermediate state between moderate and severe aortic stenosis?

Ejection fraction-velocity ratio in predicting symptoms in severe aortic stenosis

The effect of beta-blocker therapy in HF patients with high comorbidity burden: interpreting data in community setting

Comparing prognostic role of atrial fibrillation in predominantly HF elderly patients with HFrEF and HFpEF in community setting.

Quantitative contributor of comorbidities in HF patients according to HF phenotypes.

Systolic blood pressure target: a new challenge in cardiovascular prevention in community-based population?

Prognostic impact of polypharmacy drugs across heart failure phenotypes: an unmet need.

ESC 365 is supported by

Doctor Concetta Di Nora Follow

Biography

Contributor content

Recipient or donor age in heart transplantation:which one fits more?

Donor age in heart transplantation: results and controversies

Carotid artery atherosclerosis and stiffness: comparison of different metabolic measures

Paradoxical low-flow low-gradient aortic stenosis: an intermediate state between moderate and severe aortic stenosis?

Ejection fraction-velocity ratio in predicting symptoms in severe aortic stenosis

The effect of beta-blocker therapy in HF patients with high comorbidity burden: interpreting data in community setting

Comparing prognostic role of atrial fibrillation in predominantly HF elderly patients with HFrEF and HFpEF in community setting.

Quantitative contributor of comorbidities in HF patients according to HF phenotypes.

Systolic blood pressure target: a new challenge in cardiovascular prevention in community-based population?

Prognostic impact of polypharmacy drugs across heart failure phenotypes: an unmet need.

ESC 365 is supported by

Doctor Concetta Di Nora